FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Alzheimer's news from FiercePharma

News

ARBs might prevent, treat Alzheimer's

Help for Alzheimer's may already be in thousands of medicine cabinets. Researchers found that patients taking blood pressure drugs called agiotensin receptor blockers, or ARBs, were 35 percent to 40 Read more...
Tags: Diovan   Alzheimer's   ARBs  

Painkillers little help against dementia

Hopes that painkillers might help stave off Alzheimer's disease were dampened by a large new study. Pfizer's Celebrex and the over-the-counter Aleve didn't benefit thinking skills as researchers had Read more...
Tags: Pfizer   Celebrex   Bayer   Alzheimer's  

SPOTLIGHT: More good news for Alzheimer's patients

Don't plan the party yet, but there's more good news for Alzheimer's patients and statin makers alike. New research that combined cognitive monitoring before death and brain dissection afterward Read more...
Tags: Alzheimer's   Statins  

Press Releases

PRESS RELEASE: Biogen Idec and Neurimmune Announce $380M Alliance to Develop Treatments for Alzheimer's Diseases

Biogen Idec and Neurimmune Announce $380M Alliance to Develop Treatments for Alzheimer's Diseases Cambridge, MA and Zürich, Switzerland, November 20, 2007 – Biogen Idec and Neurimmune Read more...

PRESS RELEASE: Children With Alzheimer's Disease Risk Gene Show Reduced Cognitive Function

Children With Alzheimer's Disease Risk Gene Show Reduced Cognitive Function Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive Read more...

PRESS RELEASE: An Alzheimer’s Vaccine?

Oklahoma City, Nov. 12, 2007 – Could a new vaccine be the key to stopping Alzheimer’s disease? A new research study from the Oklahoma Medical Research Foundation shows that immunization could Read more...

PRESS RELEASE: Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease

Memory Pharmaceuticals Announces Positive Phase 2a Results for MEM 3454 in Alzheimer's Disease MONTVALE, N.J., Nov. 2 -- Memory Pharmaceuticals Corp. today announced positive top-line data from the Read more...

PRESS RELEASE: UCLA scientists pinpoint a possible physical origin of Alzheimer's disease

UCLA scientists pinpoint a possible physical origin of Alzheimer's disease Discovery suggests new ways to treat disorder's cause, not just symptoms FINDINGS: For some time, scientists have blamed Read more...

Get more Alzheimer's coverage at: